Abstract
Ambient noise is a critical factor affecting the precision of mobile hearing tests conducted in home environments. Monitoring noise levels during out-of-booth measurements provides essential information about the suitability of the setting for accurate audiometric testing. When ambient noise is controlled, results are expected to be comparable to in-booth measurements. This study remotely conducted air-conduction pure-tone audiometry and adaptive categorical loudness scaling (ACALOS) tests at 0.25, 1, and 4 kHz using a smartphone, while an integrated microphone and a dosimeter app were used to quantify ambient noise levels. Additionally, a reinforced ACALOS (rACALOS) method was proposed to integrate threshold measurement into the ACALOS procedure. The rACALOS method not only improves the accuracy of threshold estimation but also increases efficiency by combining two independent procedures into a single, streamlined process. As a result, ambient noise levels were mostly below the maximum permissible level. Hearing tests conducted via smartphone demonstrated moderate-to-excellent reliability, with intraclass correlation coefficients (ICCs) exceeding 0.75, and strong validity, with biases of less than 1 dB. In simulations, the rACALOS method reduced the bias towards pre-assumed thresholds, and in behavioral experiments, it showed a stronger correlation with pure-tone audiometric thresholds than the baseline method. Overall, this study demonstrates that administering pure-tone audiometry and ACALOS tests at home is feasible, valid, efficient, and reliable when ambient noise is sufficiently low.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy EXC 2177/1 - Project ID 390895286.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Research Ethics Committee of the University of Oldenburg gave ethical approval for this work (Drs. EK/2023/004).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
